U.S. Markets open in 4 hrs 5 mins

Zynex, Inc. (ZYXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
18.89-0.23 (-1.20%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close19.12
Bid0.00 x 1300
Ask21.00 x 1100
Day's Range18.32 - 19.66
52 Week Range7.51 - 29.73
Avg. Volume1,320,112
Market Cap647.702M
Beta (5Y Monthly)1.08
PE Ratio (TTM)59.03
EPS (TTM)0.32
Earnings DateJul 28, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 31, 2018
1y Target Est27.35
  • Zynex, Inc (ZYXI) Q2 2020 Earnings Call Transcript
    Motley Fool

    Zynex, Inc (ZYXI) Q2 2020 Earnings Call Transcript

    Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI)Q2 2020 Earnings CallJul 28, 2020, 4:15 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to the Zynex Second Quarter 2020 Earnings Call.

  • Benzinga

    Recap: Zynex Q2 Earnings

    Shares of Zynex (NASDAQ:ZYXI) increased 2.65% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 50.00% year over year to $0.09, which were in line with the estimate of $0.09.Revenue of $19,263,000 up by 87.07% year over year, which beat the estimate of $19,120,000.Guidance Zynex hasn't issued any earnings guidance for the time being.Revenue guidance hasn't been issued by the company for now.How To Listen To The Conference Call Date: Jul 28, 2020View more earnings on ZYXITime: 04:15 PMET Webcast URL: https://www.webcaster4.com/Webcast/Page/1487/36138Recent Stock Performance Company's 52-week high was at $29.73Company's 52-week low was at $7.51Price action over last quarter: Up 15.12%Company Overview Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave, Non-Invasive Blood Volume Monitor and others.See more from Benzinga * Earnings Scheduled For July 28, 2020 * Benzinga's Top Upgrades, Downgrades For July 20, 2020 * 20 Healthcare Stocks Moving In Wednesday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Zynex (ZYXI) to Report Q2 Earnings: What's in the Cards?

    Zynex (ZYXI) to Report Q2 Earnings: What's in the Cards?

    Zynex's (ZYXI) April orders down approximately 35% from the January and February average. This may have impacted its Q2 earnings.